MSB Monday Opening Price, page-122

I've obviously managed to inadvertently get under your skin by coming around and suggesting that these results may not be what they seem on the surface.

While also explaining how I actually think the fundamentals of MSB are interesting from a medical standpoint.

But you've completely glossed over what I've actually come here and said.

You aren't interested in hearing what you don't want to, and that's fine my friend.

But if a bunch of doctors had huge reservations over the interpretation of a preliminary data set involving a medical company targeted at patients they are actively involved in treating, I'd want to know if I was an investor. (It's not just me who was discussing this around the ICU today).

To each their own.

Good luck to all